Marlana Orloff Dacey, MD
Assistant Professor
Alexander & Johnston Family Endowed Clinical Director in Uveal Melanoma
![Marlena Orloff, MD](/content/academic/academics/colleges-schools-institutes/skmc/departments/medical-oncology/faculty/orloff-dacey/_jcr_content/profile/image.img.jpg)
Contact
925 Chestnut Street
Suite 1014
Philadelphia, PA 19107
215-955-8874
215-503-2715 fax
Marlana Orloff Dacey, MD
Assistant Professor
Alexander & Johnston Family Endowed Clinical Director in Uveal Melanoma
Education
Medical School
Penn State College of Medicine, Philadelphia, PA - 2009
Residency
Thomas Jefferson University, Philadelphia, PA
Fellowship
Thomas Jefferson University, Philadelphia, PA
Most Recent Peer-Reviewed Publications
- Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis
- Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
- Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
- Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)
- Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: A phase 1 study
Board Certification
Internal Medicine
Medical Oncology